NNVC
NanoViricides, Inc.
There isn't enough reported data to score NNVC yet.
NNVC Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
NNVC's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
NNVC PE Valuation
NNVC has no meaningful PE right now: it lost money over the past year.
NNVC Forward outlook
There aren't enough analyst estimates for NNVC to show an outlook.
NNVC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.41 | +$0.22 |
| Q1 2026 | -$0.42 | +$0.28 |
| Q4 2025 | -$0.47 | +$0.25 |
| Q3 2025 | -$0.50 | +$0.26 |
| Q2 2025 | -$0.63 | +$0.07 |
| Q1 2025 | -$0.70 | +$0.11 |
| Q4 2024 | -$0.72 | +$0.08 |
| Q3 2024 | -$0.76 | +$0.01 |
NNVC is still losing money, but far less than before: $0.41 per share over the past year, against $2.75 at its worst in early 2020.
NNVC Quarterly Revenue
NNVC's revenue is shrinking: $0 last quarter.
NNVC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.1M | -$409.8K |
| Q1 2026 | -$1.9M | +$60.4K |
| Q4 2025 | -$2M | +$141.3K |
| Q3 2025 | -$1.7M | +$963.5K |
| Q2 2025 | -$1.7M | -$132.6K |
| Q1 2025 | -$2M | -$2.8K |
| Q4 2024 | -$2.2M | -$466.5K |
| Q3 2024 | -$2.6M | -$1.5M |
NNVC has burned cash in almost every quarter: −$8M over the past year, against −$9M the year before.
NNVC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +8.9% | +1.8M shares |
| 1 year | +35% | +5.6M shares |
| 3 years | +86% | +10M shares |
| 5 years | +97% | +10.7M shares |
| Available history | +462% | +17.8M shares |
NNVC has 22M diluted shares, up 35% from a year ago.
NNVC Net Leverage
NNVC's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NNVC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.5 | Neutral |
| Stochastic | 43.1 | Neutral |
NNVC's weekly RSI is 50 (neutral) and its Stochastic is 43 (neutral).
NNVC PE vs Healthcare Sector
NNVC has no meaningful PE right now: it lost money over the past year.
NNVC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.35 | 0% above |
| 20 week MA | $1.37 | 1.5% below |
| 50 week MA | $1.27 | 6.3% above |
| 100 week MA | $1.34 | 0.7% above |
| 200 week MA | $1.37 | 1.5% below |
NNVC's trend is mixed: it's above two of its five weekly moving averages, and 1.5% below its 200-week average.
NNVC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.64 | $3.51 | +33% |
| 2021 | $3.51 | $3.94 | +12% |
| 2022 | $3.94 | $1.20 | -70% |
| 2023 | $1.20 | $1.02 | -15% |
| 2024 | $1.02 | $1.50 | +47% |
| 2025 | $1.50 | $1.19 | -21% |
| 2026 YTD | $1.19 | $1.35 | +13% |
NNVC has finished lower in three of the last six years. It's up 13% so far in 2026.